Differential Drug Target Selection in Blood Coagulation: What can we get from Computational Systems Biology Models?

Author(s): Mikhail A. Panteleev, Anna A. Andreeva, Alexey I. Lobanov*.

Journal Name: Current Pharmaceutical Design

Volume 26 , Issue 18 , 2020

Become EABM
Become Reviewer


Discovery and selection of the potential targets are some of the important issues in pharmacology. Even when all the reactions and the proteins in a biological network are known, how does one choose the optimal target? Here, we review and discuss the application of the computational methods to address this problem using the blood coagulation cascade as an example. The problem of correct antithrombotic targeting is critical for this system because, although several anticoagulants are currently available, all of them are associated with bleeding risks. The advantages and the drawbacks of different sensitivity analysis strategies are considered, focusing on the approaches that emphasize: 1) the functional modularity and the multi-tasking nature of this biological network; and 2) the need to normalize hemostasis during the anticoagulation therapy rather than completely suppress it. To illustrate this effect, we show the possibility of the differential regulation of lag time and endogenous thrombin potential in the thrombin generation. These methods allow to identify the elements in the blood coagulation cascade that may serve as the targets for the differential regulation of this system.

Keywords: Blood coagulation, thrombin generation, plasma clotting, mathematical model, antithrombotic, sensitivity.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [2109 - 2115]
Pages: 7
DOI: 10.2174/1381612826666200406091807
Price: $65

Article Metrics

PDF: 10